Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine
Open Access
- 5 January 2006
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 354 (1), 23-33
- https://doi.org/10.1056/nejmoa052664
Abstract
Rotavirus is a leading cause of childhood gastroenteritis and death worldwide.Keywords
This publication has 28 references indexed in Scilit:
- Novel Rotavirus VP7 Typing Assay Using a One-Step Reverse Transcriptase PCR Protocol and Product Sequencing and Utility of the Assay for Epidemiological Studies and Strain Characterization, Including Serotype Subgroup AnalysisJournal of Clinical Microbiology, 2005
- Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccineReviews in Medical Virology, 2004
- An Analysis of Rotavirus Vaccine Reports to the Vaccine Adverse Event Reporting System: More Than Intussusception Alone?PEDIATRICS, 2004
- Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infantsThe Journal of Pediatrics, 2004
- Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countriesVaccine, 1999
- Serologic Correlates of Immunity in a Tetravalent Reassortant Rotavirus Vaccine TrialThe Journal of Infectious Diseases, 1997
- Review Of G And P Typing Results From A Global Collection Of Rotavirus Strains: Implications For Vaccine DevelopmentThe Journal of Infectious Diseases, 1996
- Anti-Rotavirus G Type-Specific and Isotype-Specific Antibodies in Children with Natural Rotavirus InfectionsThe Journal of Infectious Diseases, 1994
- Comparison of seven kits for detection of rotavirus in fecal specimens with a sensitive, specific enzyme immunoassayDiagnostic Microbiology and Infectious Disease, 1987
- SEQUENTIAL ENTERIC ILLNESSES ASSOCIATED WITH DIFFERENT ROTAVIRUS SEROTYPESThe Lancet, 1978